THTakehiro Hashikata

Takehiro Hashikata

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Takehiro Hashikata has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Stellate ganglion phototherapy for electrical storm during mechanical circulatory support in acute coronary syndrome: a case series

    by Yuki Arakawa, Takehiro Hashikata, Yuki Ikeda, Nobuhiro Sato, Hidehira Fukaya, Junya Ako

    Background: Electrical storm (ES) during mechanical circulatory support (MCS) in the setting of acute coronary syndrome (ACS) represents a life-threatening condition driven by sympathetic hyperactivation and repolarization abnormalities. While stellate ganglion block is recognized as an effective autonomic modulation strategy for drug-refractory ventricular arrhythmias, its use may raise concerns regarding bleeding complications in patients receiving systemic anticoagulation. Stellate ganglion phototherapy (SGP) is a non-invasive alternative, but its clinical utility for ES under MCS remains unclear. Case summary: This case series describes two patients with drug-refractory ES complicating ACS during MCS management. Patient 1, a 78-year-old woman with cardiogenic shock, developed recurrent ventricular fibrillation (VF) with QT prolongation while on veno-arterial extracorporeal membrane oxygenation. Overdrive pacing caused haemodynamic deterioration, and conventional antiarrhythmic drugs failed. Following SGP initiation, no further VF requiring electrical shocks occurred. Extracorporeal membrane oxygenation was subsequently withdrawn. Patient 2, a 77-year-old man, developed recurrent torsades de pointes/VF with QT prolongation after left main revascularization under Impella support. Following SGP initiation, no further episodes requiring electrical shocks occurred. Impella was subsequently removed. Discussion: Stellate ganglion phototherapy may represent a non-invasive autonomic modulation strategy for drug-refractory ES in ACS patients requiring MCS. Although concomitant therapies and gradual recovery from myocardial ischaemia may have contributed to arrhythmia suppression, the temporal association suggests a potential contribution of SGP. Stellate ganglion phototherapy may serve as a bridge to recovery when invasive approaches pose additional challenges.

  • Top Cited Papers

    Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial

    by William F. Fearon, Kosei Terada, Kuniaki Takahashi, Anette Skoda, Helen I. Luikart, Cynthia A. Lamendola, Frederik M. Zimmermann, Takehiro Hashikata, Kan Saito, Akihiro Yoshida, et al.

    BACKGROUND: Cardiac allograft vasculopathy is an important cause of mortality after heart transplantation (HT). Dyslipidemia is a major contributor to the development of cardiac allograft vasculopathy. The safety and effectiveness of proprotein convertase subtilisin/kexin 9 inhibition to lower cholesterol and to prevent cardiac allograft vasculopathy early after HT are not well established. METHODS: In this investigator-initiated, prospective, multicenter, double-blind randomized trial, participants were randomized early after HT to receive either alirocumab or placebo in addition to rosuvastatin. Before randomization and at 1 year, all participants underwent invasive coronary assessment, including angiography, fractional flow reserve, coronary flow reserve, the index of microcirculatory resistance, and intravascular ultrasound with near-infrared spectroscopy. Lipid values were assessed at baseline and at prespecified intervals. The primary end point was the change in coronary artery plaque volume from baseline to 1 year after HT based on serial intravascular ultrasound. RESULTS: A total of 114 HT recipients were included (57 assigned to alirocumab and 57 assigned to placebo). Baseline characteristics were well matched between the 2 groups. The low-density lipoprotein cholesterol levels decreased significantly from baseline to 1 year in the alirocumab arm (72.7±31.7 to 31.5±20.7 mg/dL; P P =0.92). Plaque volume increased numerically in both groups from baseline to 12 months (alirocumab, 176.3±95.2 to 184.5±105.4 mm³; P =0.23; placebo 173.7±96.7 to 183.1±109.8 mm 3 ; P =0.15). The change in plaque volume (mean difference in differences) did not differ between groups (1.01 [0.89–1.14]; P =0.86). Fractional flow reserve, coronary flow reserve, and the index of microcirculatory resistance did not change significantly with the addition of alirocumab. There were no significant adverse events related to alirocumab. CONCLUSIONS: Proprotein convertase subtilisin/kexin 9 inhibition with alirocumab in addition to statin therapy early after HT safely lowers low-density lipoprotein cholesterol but did not reduce coronary artery plaque progression after 1 year compared with rosuvastatin alone in patients with a low baseline low-density lipoprotein cholesterol. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03537742.


  • Open Access

    High Radial Artery Puncture Reduces CRPS Risk for Women: A Retrospective Case Series

    by Takehiro Hashikata, Masahiko Shibuya, Yoshiaki Shintani, Koichi Miyazaki, Yuji Okuno

    Background/Objectives: Radial artery access (RAA) is widely used for catheter-based procedures due to its safety and convenience, but complex regional pain syndrome (CRPS) remains a rare, underrecognized complication—particularly in women. CRPS manifests as prolonged, severe pain and autonomic symptoms, often associated with nerve irritation near the carpal tunnel. This study aimed to evaluate whether modifying the puncture site to a high radial artery puncture (HRAP) reduces the risk of CRPS in patients undergoing transarterial micro-embolization (TAME) for frozen shoulder. Methods: We retrospectively reviewed 97 patients (47 women and 50 men) who underwent transarterial micro-embolization (TAME) via conventional RAA for frozen shoulder between February and June 2019. The occurrence of CRPS and vascular complications was recorded. All punctures were ultrasound-guided. Results: Among women treated via conventional RAA, five developed CRPS and one had radial artery occlusion. CRPS symptoms included intense puncture site pain (mean duration was 47 days), which severely impaired daily function. No complications occurred in men. Following the adoption of HRAP, no cases of CRPS, prolonged pain, or vascular complications were observed in the consecutive 101 women treated. Conclusions: Our findings suggest HRAP reduces CRPS risk by avoiding superficial nerve branches and targeting deeper arterial segments with fewer sensory structures. This ultrasound-guided modification is simple, does not require additional training, and may be widely applicable in both musculoskeletal and cardiovascular interventions. HRAP may help minimize neuropathic complications in broader patient populations.

  • Impact of Serial Coronary Stenoses on Various Coronary Physiologic Indices

    by Jung-Min Ahn, Takaharu Nakayoshi, Takehiro Hashikata, Kuninobu Kashiyama, Hiroyuki Arashi, Jihoon Kweon, Marcel Van’t Veer, Jennifer Lyons, William F. Fearon

    Background: Determining the functional significance of each individual coronary lesion in patients with serial coronary stenoses is challenging. It has been proposed that nonhyperemic pressure ratios, such as the instantaneous wave free ratio (iFR) and the ratio of resting distal to proximal coronary pressure (Pd/Pa) are more accurate than fractional flow reserve (FFR) because autoregulation should maintain stable resting coronary flow and avoid hemodynamic interdependence (cross-talk) that occurs during hyperemia. This study aimed to measure the degree of hemodynamic interdependence of iFR, resting Pd/Pa, and FFR in a porcine model of serial coronary stenosis. Methods: In 6 anesthetized female swine, 381 serial coronary stenoses were created in the left anterior descending artery using 2 balloon catheters. The degree of hemodynamic interdependence was calculated by measuring the absolute changes in iFR, resting Pd/Pa, and FFR across the fixed stenosis as the severity of the other stenosis varied. Results: The hemodynamic interdependence of iFR, resting Pd/Pa, and FFR was 0.039±0.048, 0.021±0.026, and 0.034±0.034, respectively (all P P P <0.001). Conclusions: When assessing serial coronary stenoses, nonhyperemic pressure ratios are affected by hemodynamic interdependence. When the functional significance of serial coronary stenoses is severe, the effect is similar to that which is seen with FFR.


  • Impact of Diastolic Vessel Restriction on Quality of Life in Symptomatic Myocardial Bridging Patients Treated With Surgical Unroofing: Preoperative Assessments With Intravascular Ultrasound and Coronary Computed Tomography Angiography

    by Takehiro Hashikata, Yasuhiro Honda, Hanjay Wang, Vedant S. Pargaonkar, Takeshi Nishi, M. Brooke Hollak, Ian S. Rogers, Koen Nieman, Paul G. Yock, Peter J. Fitzgerald, et al.

    Download figure Download PowerPoint Background: Despite optimal medical therapy, a myocardial bridge (MB) can cause life-limiting symptoms in a subset of patients. While surgical unroofing has been shown to improve MB-derived refractory angina, diagnostic indices of clinical symptoms and predictors of improvement following surgery are yet to be elucidated. Methods: To identify determinants of preoperative symptoms and their improvement following the surgery, preoperative intravascular ultrasound (IVUS) and coronary computed tomography angiography were evaluated in 111 patients with symptomatic MB who underwent surgical unroofing. The primary outcome was the Seattle Angina Questionnaire summary score (the average of physical limitation, angina frequency, and quality of life scores). In addition to standard anatomic variables of an MB, degrees of extrinsic vessel restriction at end-diastole and end-systole were evaluated by IVUS using the ratio of measured vessel area and interpolated reference at the maximum compression site. The diastolic restriction was also evaluated by coronary computed tomography angiography as the maximum lumen area stenosis within the MB segment. Results: Even during diastole, IVUS revealed vessel restriction in 87% of the patients. Among the variables evaluated, vessel restriction was the strongest parameter correlating with the preoperative Seattle Angina Questionnaire summary score, particularly when assessed in diastole (PP=0.006 in coronary computed tomography angiography). The diastolic restriction by IVUS also showed a weak, but significant correlation with improvement in Seattle Angina Questionnaire summary score 6 months after surgery (P=0.004). Conclusions: Restricted arterial relaxation in diastole, rather than the degree of systolic compression or extent of an MB, seems to be the primary determinant of clinical symptoms and improvement in quality of life following surgical unroofing.


  • Open Access

    Successful Retrieval of Entrapped Guide Extension Catheter in the Right Coronary Artery with Heavy Calcifications

    by Shinji Imura, Takehiro Hashikata, Motosu Ando, Fumitaka Hosaka

    Usage of an optimal guide extension catheter often helps successful outcomes in complex percutaneous coronary intervention. Here, we report a case of successfully retrieving a guide extension catheter entrapped by a coronary stent in the middle RCA. The guide extension catheter was retrieved by anchoring with the stent delivery balloon. Also, our in vitro experiment demonstrated that a "deep seating method" and an "anchoring guide extension catheter method" could be effective in bailing out guide extension catheter entrapment.


  • IMPACT OF DIASTOLIC VESSEL RESTRICTION ON CLINICAL SYMPTOMS IN PATIENTS WITH SYMPTOMATIC MYOCARDIAL BRIDGING

    by Takehiro Hashikata, Yasuhiro Honda, Hanjay Wang, Vedant Pargaonkar, M Brooke Hollak, Ian S Rogers, Paul Yock, Peter Fitzgerald, Ingela Schnittger, Jack Boyd, et al.

  • Empagliflozin attenuates neointimal hyperplasia after drug-eluting-stent implantation in patients with type 2 diabetes

    by Takehiro Hashikata, Masayasu Ikutomi, Takahiro Jimba, Akito Shindo, Nobutaka Kakuda, Susumu Katsushika, Masaaki Yokoyama, Mikio Kishi, Takahiro Sato, Masashiro Matsushita, et al.

    The effects of empagliflozin, a sodium-glucose co-transporter 2 inhibitor, on neointimal response after drug-eluting-stent (DES) implantation remains unknown. Insufficiently controlled diabetes patients with coronary artery disease planned for DES stenting were consecutively enrolled. The patients were assigned to receive empagliflozin in addition to standard therapy or intensive therapy using other glucose-lowering drugs (oGLD). The primary endpoint was thickness of neointimal hyperplasia (NIH) 12 months after stenting assessed by optical coherence tomography (OCT). A total of 28 patients were analyzed (n = 15 in the empagliflozin group, n = 13 in the oGLD group). The levels of glucose profile were not significantly different between both groups at follow-up [HbA1c; 7.2 ± 0.8 vs 7.3 ± 0.9%, p = 0.46]. In OCT analysis, neointima was significantly less in the empagliflozin group than the oGLD group [mean NIH thickness: 137 ± 32 vs 168 ± 39 μm, p = 0.02]. Changes of systolic and diastolic blood pressure (BP), changes of body mass index, and changes of hematocrit after additional treatment were significantly associated with NIH attenuation, whereas no correlation was observed in changes in blood glucose parameters. Multivariate logistic regression analysis revealed that changes in systolic BP was the strongest predictor for NIH attenuation, followed by changes in diastolic BP. In patients with type 2 diabetes, standard plus empagliflozin attenuated neointimal progression as compared with intensive standard therapy after DES implantation. Our data possibly support a beneficial effect of empagliflozin in type 2 diabetes required for coronary revascularization therapy.